ATLASInsight Molecular Diagnostics (IMDX) earnings date: Nov 9, 2026
Insight Molecular Diagnostics (IMDX) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, after the close. Analysts expect EPS of -$0.22.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on IMDX
| Last price | $2.90 (-2.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.1% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Insight Molecular Diagnostics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Insight Molecular Diagnostics reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Insight Molecular Diagnostics. You can switch it off at any time.
Alert me before IMDX reportsFree to start. Creating an account takes under a minute.
Notify me when Insight Molecular Diagnostics reports
Track IMDX free Add Insight Molecular Diagnostics to a free ATLAS watchlist and see its next report date in one place.
IMDX earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.22 |
| Last report | Aug 10, 2026 · Miss |
| Beat rate (last 4 reports) | 1 of 4 (25%) |
| Average EPS surprise | -56.8% |
| Average move around a report | ±14.6% (last 4) |
| Sector | Healthcare · Diagnostics & Research |
Insight Molecular Diagnostics earnings history: last 4 reports
Insight Molecular Diagnostics last reported on Aug 10, 2026: EPS of -$0.24 against an estimate of -$0.23 (-4.3% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.23 | -$0.24 | -4.3% | Miss | -8.3% |
| Jun 10, 2026 | -$0.77 | -$1.36 | -76.6% | Miss | -7.2% |
| May 13, 2026 | -$0.26 | -$0.12 | +53.8% | Beat | +28.9% |
| Mar 26, 2026 | -$0.24 | -$0.72 | -200.0% | Miss | -14.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for IMDX
See the fair value, the probability range and the earnings history of Insight Molecular Diagnostics on its ATLAS page.
Insight Molecular Diagnostics (IMDX) stock analysisPlans from €3.99 a month.
Insight Molecular Diagnostics earnings: frequently asked questions
When does Insight Molecular Diagnostics (IMDX) report earnings?
Insight Molecular Diagnostics is scheduled to report on Monday, November 9, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for IMDX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.22 per share (USD). Estimates can change before the report.
How often does IMDX beat earnings estimates?
Of its last 4 reports with a recorded result, Insight Molecular Diagnostics beat the EPS estimate 1 times; the average surprise was -56.8%. Past results do not predict the next one.
How much does IMDX move around earnings?
Over its last 4 reports the stock moved an average of 14.6% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Insight Molecular Diagnostics beat earnings estimates last quarter?
Insight Molecular Diagnostics last reported on Aug 10, 2026: EPS of -$0.24 against an estimate of -$0.23 (-4.3% surprise), a miss.
How much does IMDX usually move in a day?
On a normal trading day the ATLAS model puts IMDX’s one-day range at about ±5.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer